Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 5/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 5/20 | 1.00 |
| ▸ | GAA | P10253 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 1.00 |
| ▸ | CA4 | P22748 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | ALPL | P05186 | 2/20 | 1.00 |
| ▸ | ALPI | P09923 | 2/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 1.00 |
| ▸ | XDH | P47989 | 2/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 1.00 |
| ▸ | KDM1A | O60341 | 1/20 | 1.00 |
| ▸ | HMGB1 | P09429 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoquercetin SCHEMBL181306 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL15147267 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL2286562 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL12710506 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL6849311 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL561412 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL24609 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL19214052 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL21244358 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL672012 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113720929-A | Method for distinguishing albino and etiolated variety finished tea | 中国农业科学院茶叶研究所 | 2021-11-30 | — | — | CN | claimed |
| EP-4687934-B1 | A NATURAL MATRIX MIXTURE FOR THE TREATMENT OF BONE FRAGILITY | BIOS THERAPY PHYSIOLOGICAL SYSTEMS FOR HEALTH S P A (IT) | 2026-03-18 | — | — | EP | disclosed |
| EP-4696314-A1 | A NATURAL MATRIX MIXTURE FOR THE TREATMENT OF BONE FRAGILITY | Bios-Therapy, Physiological Systems for Health S.p.A. (IT) | 2026-02-18 | — | — | EP | disclosed |
| CN-119086739-A | Method for measuring content of effective components in lotus leaf and preparation thereof | 清华大学 | 2024-12-06 | — | — | CN | disclosed |
| CN-119074747-A | A product for treating helicobacter pylori negative chronic atrophic gastritis with intestinal metaplasia and/or with abnormal hyperplasia and preventing gastric cancer, and its treatment method | 清华大学 | 2024-12-06 | — | — | CN | disclosed |
| CN-113720929-A | Method for distinguishing albino and etiolated variety finished tea | 中国农业科学院茶叶研究所 | 2021-11-30 | — | — | CN | disclosed |
| US-20200315998-A1 | COMPOSITION FOR IMPROVING INTESTINAL BARRIER FUNCTION | SUNTORY HOLDINGS LIMITED (JP) | 2020-10-08 | — | — | US | disclosed |
| CN-107073026-A | Bioactive substance for treating hyperglycemic disorder is combined | 百益康食品股份有限公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-103599146-B | A kind of preparation method of diuretic compositions and purposes | HUAIHAI INSTITUTE OF TECHNOLOGY (CN) | 2016-04-27 | — | — | CN | disclosed |
| CN-103599146-A | Preparation method and use of diuretic composition | HUAIHAI INST TECHNOLOGY | 2014-02-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200315998-A1 | COMPOSITION FOR IMPROVING INTESTINAL BARRIER FUNCTION | FABP2, SLC10A2, VIP | P4HB 3227/4885KDM4E 4310/4885AKR1B1 1240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.